FOXA1 and steatosis: This study concluded that the direct activation of GLP-1R by exendin-4 reduces steatosis in an in vitro model via stimulation of the Wnt/β-catenin signaling pathway and reduces FOXA1 expression and FABP1 expression, resulting in decreased FFA uptake [49].